—A new study of more than 42,000 patients sought to evaluate contemporary trends in testing for biomarkers of non-small cell lung cancer (NSCLC), as well as rates of treatment with ...
Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...
Integrating plasma next-generation sequencing (NGS) alongside tissue testing when determining lung cancer diagnosis may improve outcomes for patients. Carrying out plasma next-generation sequencing ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Diaceutics PLC, (AIM: DXRX) today publishes new research which predicts that the Non-Small Cell Lung Cancer (NSCLC) testing market will expand to $3.6 billion in the ...
The US Food and Drug Administration (FDA) has granted approval for Thermo Fisher Scientific's Oncomine Dx Target Test as a treatment for non-small cell lung cancer (NSCLC). The test serves as a ...
Please provide your email address to receive an email when new articles are posted on . National Comprehensive Cancer Network guidelines recommend all patients with advanced nonsquamous non-small cell ...
Charu Aggarwal, M.D., MPH: Recent data show that there are many challenges. We saw presentations at this year’s American Society of Clinical Oncology annual meeting where rates of molecular testing ...
Two medical oncologists break down the role molecular testing has when treating NSCLC, from guidelines to common methods to barriers. Joshua Sabari, MD: I recommend testing up front. All patients with ...
Charu Aggarwal, M.D., MPH: I normally approach molecular testing exactly how you pointed out, Hoss. I spend at least more than half of my first visit with my patients with newly diagnosed lung cancer ...
An international survey sent to clinicians who treat nonsmall cell lung cancer (NSCLC) has found that one third were unaware of evidence-based guidelines that recommend targeted therapies when a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback